<DOC>
	<DOCNO>NCT02344511</DOCNO>
	<brief_summary>Dalbavancin Pediatric Osteomyelitis</brief_summary>
	<brief_title>Dalbavancin v Comparator Pediatric Subjects With Acute Hematogenous Osteomyelitis</brief_title>
	<detailed_description>A Phase 3 , Multicenter , Double-Blind , Randomized , Comparator Controlled Trial Safety Efficacy Dalbavancin versus Active Comparator Pediatric Subjects Acute Hematogenous Osteomyelitis Long Bones Known Suspected due Gram-Positive Organisms .</detailed_description>
	<mesh_term>Osteomyelitis</mesh_term>
	<mesh_term>Oxacillin</mesh_term>
	<mesh_term>Cefazolin</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<mesh_term>Dalbavancin</mesh_term>
	<mesh_term>Teicoplanin</mesh_term>
	<mesh_term>Nafcillin</mesh_term>
	<criteria>1 . Male female 216 yrs 2. diagnosis Acute Hematogenous Osteomyelitis ( AHOM ) long bone ( ulna , radius , femur , tibia ) define follow clinical sign symptom ( &lt; 2 week duration ; multiple site infection within long bone ) : 3 . Limb abnormality : Pain , point tenderness upon palpation , motion restriction , loss function 4 . Magnetic resonance imaging ( MRI ) OR Grampositive cocci document Gramstain bone specimen blood culture . 5 . Elevated CReactive Protein ( CRP ) 6. informed consent 7. willing able comply study protocol 8 . Life Expectancy appropriate antibiotic therapy thru study duration 1 . Treatment investigational drug within 30 day precede first dose study medication . 2 . Receipt &gt; 24 hour potentially effective intravenous antibacterial therapy AHOM within 96 hour randomization , unless pathogen isolate documented Methicillin resistant Staphylococcus aureus ( MRSA ) resistant administer antibiotic . 3 . Evidence subacute chronic osteomyelitis include : symptom &gt; 2 week duration 4 . AHOM nonlong bone ( e.g. , pelvis spine ) . 5 . Extraosseous finding : subperiosteal abscess , pyomyositis , venous thrombosis , pulmonary embolism . 6 . Previous history septic arthritis osteomyelitis . 7 . Major trauma , openfracture , puncture wound foot , postoperative osteomyelitis , foreign body adjacent affect bone joint , iatrogenic bone joint infection present site infection . 8 . Septic arthritis noncontiguous osteomyelitis 9 . Immunosuppression/immune deficiency 10 . Evidence Gramnegative bacteria gram stain absence Grampositive organism ; fungus mycobacteria baseline . 11 . Gramnegative bacteremia , even presence grampositive infection grampositive bacteremia . 12 . A history oral ulcer precede onset musculoskeletal finding , recent gastrointestinal surgery ( within 2 month ) 13 . Infection due organism know prior study entry susceptible dalbavancin ( dalbavancin mean inhibitory concentration &gt; 0.12 µg/mL ) vancomycin ( vancomycin mean inhibitory concentration ( MIC ) &gt; 2 μg/mL ) . 14 . Concomitant systemic antibacterial therapy Grampositive infection ( eg . Rifampin , gentamicin ) . 15 . Concomitant condition require antibiotic therapy would interfere assessment study drug condition study . 16 . Sickle cell anemia . 17 . Cystic fibrosis . 18. hypersensitivity glycopeptide antibiotic . 19. expect survive 3 month . 20 . Positive urine ( serum ) pregnancy test 21 . Women Child Bearing Potential unwilling unable use adequate contraceptive precaution . 22 . Other severe acute chronic medical psychiatric condition would make patient inappropriate entry study . 23 . Unwilling unable follow study procedure .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>